英语翻译Six Future High-Growth Areas in Industry1.Commercialization of Dormant CompoundsCompanies often have a reservoir of compounds that they abandoned prior to FDA approval,or that they did not commercialize.Finding ways to reposition or repur

英语翻译Six Future High-Growth Areas in Industry1.Commercialization of Dormant CompoundsCompanies often have a reservoir of compounds that they abandoned prior to FDA approval,or that they did not commercialize.Finding ways to reposition or repur
英语翻译
Six Future High-Growth Areas in Industry
1.Commercialization of Dormant Compounds
Companies often have a reservoir of compounds that they abandoned prior to FDA approval,or that they did not commercialize.Finding ways to reposition or repurpose these compounds is a high-growth opportunity due to the relatively low cost compared to developing new compounds.Repurposing a compound also extends the life of patent protection.
2.Generic or Biosimilar Versions of Biologics
Biosimilar versions of a treatment are not identical but have enough similarity to produce comparable results.This is likely to be a high-growth area,given the upcoming expiration of patents on some high-revenue biologics.
3.Improved Research and Development Efficiency
As R&D costs increase,a focus of industry will be to identify ways in which to improve efficiency while decreasing costs.Efforts will also be made to reduce the time from discovery to regulatory approval so as to maximize the life of a patent.
4.Oncology and Central Nervous System Disorders Research
These areas of research are especially important as the global population ages,with increasing burdens of Alzheimer's disease and cancer.These trends will increase the need for new drugs in these areas.
5.Stratified Medicine and Diagnostics
Finding ways to tailor and personalize medicine,especially in the realm of diagnostic tests,presents a high-growth opportunity.Diagnostic tests are often cheaper and easier to develop than new therapies and are used by a larger segment of the population than actual therapies.
6.Fusion of Pharmaceuticals and Consumer Goods
Due to stricter regulation of consumer goods,companies specializing in these products are likely to increasingly seek individuals with experience in the pharmaceutical industry because of their ability to manage highly regulated businesses and to ensure product safety and efficacy.
Adapted from:RegentAtlantic Capital,LLC,The Continuing Evolution of the Pharmaceutical Industry:Career Challenges and Opportunities,December 2007.

英语翻译Six Future High-Growth Areas in Industry1.Commercialization of Dormant CompoundsCompanies often have a reservoir of compounds that they abandoned prior to FDA approval,or that they did not commercialize.Finding ways to reposition or repur
6个未来的高增长领域产业
1 .商业休眠化合物
公司通常有一个水库的化合物,它们被遗弃FDA批准之前,或者说他们没有商业化.设法复位或重新安排这些化合物是一个高增长的机会,由于相对较低的成本相比,开发新的化合物.Repurposing复合寿命也延长了专利保护.
2 .通用或Biosimilar版本的生物制品
Biosimilar版本的待遇并不相同,但有足够的相似性,以产生可比较的结果.这可能是一个高增长领域,因为专利即将到期的一些高收入的生物制剂.
3 .改进的研究和开发效率
由于研发成本的增加,重点行业将是确定以何种方式,以提高效率,同时降低成本.还将做出努力,以减少时间从发现到监管机构的批准,以便最大限度地提高生命的专利.
4 .肿瘤和中枢神经系统紊乱的研究
这些领域的研究特别重要,因为全球人口老化,越来越多负担阿尔茨海默氏病和癌症.这些趋势将增加,需要新的药物在这些领域.
5 .分层医学诊断
寻找途径,以定制和个性化药物,尤其是在诊断测试领域,提出了一个高增长的机会.诊断测试往往更便宜和更容易开发新的疗法和比使用一个更大的群体比实际疗法.
6 .融合的药品和消费品
由于严格的管制消费品公司,专业从事这些产品很可能会越来越多地寻求有经验的个人在制药业,因为它们有能力管理和高度管制的企业,以确保产品的安全性和有效性.
改编自：RegentAtlantic资本,有限责任公司,继续演变为制药业：就业面临的挑战与机遇,2007年12月.